dbtbiosafety.nic.in

bigmoleculewatch.com

Janssen appeals invalidation of Remicade patent to PTAB

http://www.bigmoleculewatch.com/2015/07/30/janssen-appeals-invalidation-of-remicade-patent-to-ptab

Janssen appeals invalidation of Remicade patent to PTAB. July 30, 2015. Posted by Big Molecule Watch. Janssen v. Celltrion (infliximab). On July 23, 2015, Janssen Biotech, Inc. and New York University filed a brief. Appealing the rejection of all claims of U.S. Patent No. 6,284,471. A patent covering Remicade (infliximab), to the USPTO’s Patent Trial and Appeal Board. The ’471 patent was put into. Big Molecule Watch Monthly Digest. Get Real Time Blog Posts. You will receive a verification email once you ...

bigmoleculewatch.com

Big Molecule Watch

http://www.bigmoleculewatch.com/author/big-molecule-watch

FDA Has Accepted Genentech’s BLA for Subcutaneous Rituximab. November 4, 2016. Posted by Big Molecule Watch. The FDA has accepted. Genentech’s BLA for a subcutaneous formulation of rituximab. The drug is indicated to treat non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, moderate to severe rheumatoid arthritis, Wegener’s granulomatosis and microscopic polyangiitis. According […]. Hospira Files Responsive Appeal Brief in Amgen v. Hospira Litigation. November 4, 2016. Posted by Big Molecule Watch.

bigmoleculewatch.com

IPR Tracker: IPR2015-01624 (Sanofi-aventis and Regeneron) (U.S. Patent No. 6,331,415)

http://www.bigmoleculewatch.com/2015/07/28/ipr-tracker-ipr2015-01624-sanofi-aventis-and-regeneron-u-s-patent-no-6331415

IPR Tracker: IPR2015-01624 (Sanofi-aventis and Regeneron) (U.S. Patent No. 6,331,415). July 28, 2015. Posted by Big Molecule Watch. IPR2015-01624 (Sanofi-aventis and Regeneron) (U S Patent No 6,331,415). Petitioners: Sanofi-aventis U.S. LLC and Regeneron Pharmaceuticals, Inc. Patent: U.S. Patent No. 6,331,415. Patent Title: Methods of Producing Immunoglobulins, Vectors and Transformed Host Cells for Use Therein. Amgen v. Sandoz. Federal Circuit Decision' rel"next" Next →. Big Molecule Watch Monthly Digest.

bigmoleculewatch.com

Janssen v. Celltrion

http://www.bigmoleculewatch.com/janssen-v-celltrion

Janssen v. Celltrion. Janssen Motion to Stay. Janssen Motion for Partial Summary Judgment and PI. Celltrion Hospira Answer and Defenses. Celltrion Hospira Opposition to Motion to Stay. Amended Joint Motion for Proposed Scheduling Order. Celltrion Hospira Cross Motion for Partial Summary Judgment. Celltrion Hospira Opposition to Motion for Partial Summary Judgment. Celltrion Hospira Statement of Material Facts. Celltrion Hospira Affidavit ISO Cross Motion for Partial Summary Judgment. AbbVie v. Amgen.

all-govt-job.blogspot.com

All-Govt-Job: 02/15/15

http://all-govt-job.blogspot.com/2015_02_15_archive.html

Single Place For All Type Of Government Jobs In INDIA Bank Jobs PSU Job IT Jobs. Associate/Sr. Associate -(Non Technical). Assam Gramin Vikas Bank. Jaipur Thar Gramin Bank. Sunday, 15 February 2015. Contract Job posts in UP NRHM Feb-2015. National Health Mission (NHM), Uttar Pradesh (UP). Vishal Complex, 19-A, Vidhan Sabha Marg, Lucknow - 226001(UP). Block Community Process Managers . 160; 820 posts. Rogi Sahayata Kendras Managers . Rogi Sahayata Kendra Operators. 160; 200 posts . How to Apply :. 04 post...

bigmoleculewatch.com

Goodwin Procter BioSimilars Blog: : Page 3

http://www.bigmoleculewatch.com/page/3

Welcome to the Big Molecule Watch! Introducing the world of biologics, biosimilars, and the Biologics Price Competition and Innovation Act ( BPCIA ). We’ve also collected (and will continue to update) some reference documents that might be of interest to visitors of this blog you can find them under the Links section to the right of this page. Janssen v. Celltrion. District Court Schedules Hearing on Motion to Dismiss. October 17, 2016. Posted by Big Molecule Watch. Janssen v. Celltrion (infliximab).

biosafety.org.in

Archives

http://biosafety.org.in/archive.aspx

Biosafety Online Training Programme. Regulatory norms not followed in Bt cotton fields - Survey Report, ISCI. Bill on independent regulator for biotech sector introduced in Lok Sabha. AUSTRALIA OGTR TO ISSUE LICENSE FOR CONTROLLED RELEASE OF GM WHEAT AND BARLEY. Govt reconstitutes Genetic Engineering Appraisal Committee. DISEASE RESISTANT DWARF RASPBERRY RELEASED IN THE USA. PARAGUAY APPROVES NEW BIOTECH SOYBEAN VARIETY. SCIENTISTS CALL FOR NEW REGULATIONS FOR "GROWING" MEDICINES IN PLANTS. EU JRC Notifi...

biosafety.org.in

Admission in BOTP

http://biosafety.org.in/admission.aspx

Biosafety Online Training Programme. Benefits of the Online Course Program. The course work would have offer the following:. A complete tour through the rules and regulations of biosafety and bioethics. A compact and focused study of the above, in a stipulated time. An overall understanding of the biosafety primarily in India. An online examination that would test the complete understanding of the biosafey and bioethics rules and regulations. Graduate/Post-graduate/Research Fellows of Life Sciences.

biosafety.org.in

Our Team

http://biosafety.org.in/team.aspx

Biosafety Online Training Programme. Shri S. N. Tyagi. Sector Specialist [M and E]. Gujarat State Biotechnology Mission. Department of Science and Technology, Government of Gujarat, Udyog Bhavan, 11th Block, 9th Floor, Sector - 11 Gandhinagar - 382 017 Gujarat - INDIA. Phone: ( 91) 079 23252197. E-mail: info@biosafety.org.in.